Introduction {#Sec1}
============

Malaria is endemic in over 100 countries worldwide \[[@CR62]\]. In endemic regions, it is a serious health problem with an estimated 863,000 people dying each year of which 85% are children under the age of 5 years \[[@CR59]\]. Imported malaria, i.e., malaria contracted in an endemic region but diagnosed in a non-endemic country \[[@CR33]\], is a rare event but may have a fatal outcome. Due to its rare occurrence, physicians and laboratory staff are not familiar with its diagnosis. Prompt and accurate diagnosis is, however, critical for the effective management of malaria \[[@CR44]\].

The present paper gives an overview of the clinically relevant features of the cycle of the *Plasmodium* parasite and a short reminder of the clinical presentation of malaria in children. Next, it focuses on the laboratory diagnosis of imported malaria in a non-endemic setting and gives an update on the diagnostic value and place of malaria rapid diagnostic tests.

The *Plasmodium* species {#Sec2}
========================

The parasite {#Sec3}
------------

Malaria is caused by a parasite called *Plasmodium*, which is transmitted through the bites of the infected *Anopheles* mosquito. There are four human *Plasmodium* species: *Plasmodium falciparum*, *Plasmodium vivax*, *Plasmodium ovale*, and *Plasmodium malariae.* Recently, human infections with a fifth species, *Plasmodium knowlesi*, which is usually found in monkeys, have been reported \[[@CR48]\]. Figure [1](#Fig1){ref-type="fig"} depicts the life cycle of malaria parasites in humans. A detailed description of the *Plasmodium* life cycle can be found in reference \[[@CR35]\]. Fig. 1*Plasmodium* life cycle. Retrieved from Centers for Disease Control and Prevention (CDC). Available at <http://www.cdc.gov/malaria/about/biology/>

The cycle in the human host: from liver to blood, hypnozoites, relapse, and recrudescence {#Sec4}
-----------------------------------------------------------------------------------------

*Plasmodium* has a sexual cycle inside the mosquito and an asexual cycle inside man. During the bite of an infected female mosquito, *Plasmodium* sporozoites are injected in the blood and move to liver cells where they develop into liver schizonts. After the rupture of the schizonts (approximately 1 week after infection), merozoites are released into the bloodstream and each of them will invade a RBC. There they develop into ring forms (trophozoites) which mature into schizonts that divide into merozoites which invade new RBCs. The rupture of the schizont and release of merozoites give rise to the so-called malaria paroxysms with spiking fever and rigors. The time required to complete the RBC cycle (from invading merozoites over trophozoites to rupturing schizont) depends on the species: for *P. falciparum*, *P. ovale*, *P. vivax*, and *P. ovale*, the cycle takes 48 h; for *P. malariae* and *P. knowlesi*, it takes 72 h and 24 h, respectively. In non-immune patients, however, particularly when infected with *P. falciparum*, parasites tend to mature asynchronously, resulting in irregular fever patterns \[[@CR67]\].

After 1 or 2 weeks, gametocytes, the sexual form of *Plasmodium*, will be produced. These gametocytes continue the sexual cycle when taken up by a mosquito during a next blood meal. The sexual cycle will be completed over a period of 2 weeks, where after the mosquito can infect another human host.

In case of *P. vivax* and *P. ovale* infections, dormant liver stages (hypnozoites) may cause infections (so-called relapses) weeks to months after adequate prophylaxis or effective blood-stage therapy of a primary infection. *P. malariae* may persist in the blood at undetectable levels without causing symptoms for many years and may subsequently develop into clinical illness in patients under immunosuppressive drugs or after splenectomy (these infections are referred to as recrudescence) \[[@CR67]\].

The red blood cell: differences in parasite densities among the *Plasmodium* species {#Sec5}
------------------------------------------------------------------------------------

*P. vivax* and *P. ovale* only infect young RBCs and *P. malariae* only infects old RBCs; hence, the percentages of infected RBCs (designated as "parasite density" or "parasitemia") are usually lower than 2% and 1%, respectively. By contrast, *P. falciparum* infection has not such a preference and there is no intrinsic limit to the parasite density. In addition, RBCs infected by *P. falciparum* stick to the capillary endothelium and occlude the microvascular circulation in the deep organs (a process called sequestration), leading to the manifestations of what is defined as severe malaria: metabolic acidosis, cerebral malaria (coma), renal insufficiency, and acute respiratory distress. In addition, hypoglycemia can occur. By consequence, *P. falciparum* is the most dangerous species, and infection may become fatal when treatment is delayed for more than 24 h after presentation of symptoms \[[@CR62]\]. The other species are thought to be less severe though organ involvement and case fatalities have been described for *P. vivax* as well \[[@CR41]\].

Geographic distribution of *Plasmodium* species {#Sec6}
-----------------------------------------------

*P. falciparum* is the predominant species in Africa, where *P. vivax* is virtually absent (because most Africans lack the Duffy blood group antigen which enables *P. vivax* to enter the RBC), except for some areas in Eastern Africa. *P. ovale* is mainly restricted to Africa; rare cases have been observed in Haiti and Oceania. *P. malariae* is the second common species in Africa and also distributed in other geographic areas. Latin America is predominated by *P. vivax* though *P. falciparum* is present as well. The same goes for the Indian sub-continent and South-East Asia where *P. malariae* is also prevalent.

Imported malaria in children {#Sec7}
============================

Children at risk: few tourist travelers, mostly visiting friends and relatives or immigrants {#Sec8}
--------------------------------------------------------------------------------------------

Yearly, more than 125 million international travelers visit malaria endemic countries and over 10,000 people are reported to fall ill upon return to their home country, though this number might even be as high as 30,000 \[[@CR62]\]. However, in most European countries, imported malaria has been declining during the past 10 years \[[@CR53]\]; possible explanations are the increased use of prophylaxis or a decreased transmission intensity in the visited malaria endemic areas, though this remains to be confirmed \[[@CR53]\].

Children account for 10--15% of all patients with imported malaria \[[@CR11], [@CR23], [@CR39]\] and share with pregnant women the highest risk to develop severe and life-threatening complications \[[@CR62]\]. Children of the so-called visiting friends and relatives category (further referred to as VFR children) are the main group at risk \[[@CR47]\]. VFR children are born in non-endemic countries to parents originating from malaria endemic areas and contract malaria upon visits to malaria endemic regions. Immigrated children and refugees are another risk group \[[@CR47]\]. In an Italian and a Spanish study, imported malaria in children was exclusively observed among VFR children and immigrants \[[@CR1], [@CR39]\]. These findings were confirmed in other studies, with VFR children accounting for most of the cases versus tourist travelers representing only a minor part \[[@CR11], [@CR33], [@CR34]\]. Among 194 children with imported malaria in the USA for the year 2004, more than half (54.6%) were visiting friends and relatives, and more than a quarter (28.3%) of them were refugees and immigrants. Reasons for this phenomenon are that VFR children hardly comply with preventive measures and have a poor adherence to prophylactic drugs \[[@CR1], [@CR11], [@CR33], [@CR34], [@CR39]\]. Their parents have difficult access to travel advice due to language and cultural barriers, and may also believe their children have immunity against malaria because of their ethnic origin, making prophylaxis unnecessary \[[@CR33]\]. Semi-immunity does exist in children, but only when born and grown in endemic countries. This semi-immunity wanes after a variable period (usually estimated at 6 months) of not being exposed to malaria (as in the case of migrants and refugees) \[[@CR39], [@CR49]\].

A particular group---strictly speaking not to be classified as \"import malaria\"---are autochthonous malaria cases caused by inadvertently imported *Anopheles* mosquitoes, either by airplane, ship, or baggage. Although members of airport staff are the primary victims, anecdotal cases of \"airport\" or \"baggage\" malaria have been described in children too \[[@CR28]--[@CR30]\]. As *Anopheles* mosquitoes survive transports in aircrafts, WHO recommends insecticide spraying in flights leaving endemic countries \[[@CR57]\].

Non-specific symptoms but serious complications {#Sec9}
-----------------------------------------------

A 2.5-year-based study in a district hospital in Birmingham, UK assessed 153 children presenting with fever and having traveled to the tropics or subtropics during the previous year and revealed that 14% of them had malaria \[[@CR54]\]. Although fever was reported as the major presenting symptom in up to 97.6% of children with imported malaria \[[@CR24]\], other studies revealed that 10--17% of children with malaria had no fever upon admission \[[@CR1], [@CR11]\]. Other symptoms are non-specific and may mimic diseases like gastrointestinal infections or pneumonia \[[@CR8]\].

In the UK, a total of 997 children with imported malaria were reported between 2004 and 2008, of which one third fulfilled the WHO criteria for severe malaria \[[@CR16]\]. Other studies from the UK, the Netherlands, and Canada revealed similar proportions \[[@CR11], [@CR32], [@CR34]\]. The proportions of children requiring intensive care support ranged from 3% to 40% \[[@CR11], [@CR16], [@CR34]\]; most of them survived without sequelae though cerebellar infarction was observed in one out of 10 patients with cerebral malaria \[[@CR16]\]. The case--fatality ratio of all imported malaria cases in children varied between 0.2% and 0.4% \[[@CR3], [@CR16]\].

How long after return from an endemic country can children develop malaria? {#Sec10}
---------------------------------------------------------------------------

The time between returning home after travel and onset of symptoms depends on the infecting *Plasmodium* species. In a study including 245 children positive for malaria, the median delay of *P. falciparum* infection was 5 days (range 0--330 days); for *P. vivax*, *P. ovale*, and *P. malariae*, the recorded delays were 62 (0--330), 25 (0--120), and 37 days (0--188), respectively \[[@CR65]\]. It should be reminded, however, that as a consequence of relapse (*P. ovale* and *P. vivax*) and recrudescence (*P. malariae*), clinical malaria can occur even at a later onset. Of interest, *P*. *falciparum*, which apparently lacks both features, has been reported with a delayed onset of infection in adults for up to 9 years after acquisition \[[@CR9], [@CR20], [@CR21], [@CR50]\].

Malaria diagnosis: patient delay, doctor delay, laboratory delay {#Sec11}
----------------------------------------------------------------

Diagnosis is delayed in one third of children with imported malaria \[[@CR4], [@CR12], [@CR65]\]. The median time between onset of symptoms and diagnosis of malaria was recorded as 3--4 days \[[@CR4], [@CR65]\] but can extend up to 32 days \[[@CR65]\]. Importantly with regard to pre-travel advice was that most delay was at the patient's side, with parents waiting several days before consulting, resulting in a median patient delay of 3 days (range 0--11 days) \[[@CR4]\]. The median doctor delay in that study was 0 days (which means that in most cases malaria was considered at the first presentation) but ranged up to 19 days \[[@CR4]\]. Other data about doctor delay are variable, with 2% \[[@CR1]\] to 60% \[[@CR32]\] of doctors failing to consider malaria at first presentation. Finally, there may be a considerable laboratory delay, due to the lack of a competent microbiologist on duty \[[@CR1]\] or the lack of microscopic expertise \[[@CR1], [@CR4]\]. Indeed, in non-endemic settings, since it is difficult to maintain adequate performance and expertise of the laboratory staff due to the low exposure to malaria-positive samples and especially at low parasite densities, diagnosis may easily be missed \[[@CR18], [@CR26], [@CR40]\].

*Plasmodium* species involved {#Sec12}
-----------------------------

The *Plasmodium* species involved reflect the travel destination or the country of origin of the child or his/her migrated parents. Overall, the most encountered species was *P. falciparum*, accounting for up to 90% of cases, with the majority of infections acquired in Sub-Saharan Africa \[[@CR11], [@CR23], [@CR34], [@CR65]\]. *P. vivax* infections were mostly acquired in the Indian sub-continent by VFR children whose parents were originating from these regions \[[@CR33]\]. Table [1](#Tab1){ref-type="table"} gives an overview of the species distribution and geographic origin of 147 children ≤14 years old diagnosed with malaria in our setting (Institute of Tropical Medicine, Antwerp, Belgium). Table 1Malaria in children ≤14 years as diagnosed at the Institute of Tropical Medicine, Antwerp, Belgium during the period 1995--2010: species distribution according to region of acquisitionSpeciesRegion where malaria was acquiredTotal (%)East AfricaMiddle AfricaWest AfricaAsiaNo data*P. falciparum*42952224111 (75.5)*P. falciparum*/*P. malariae*22 (1.4)*P. malariae*2237 (4.8)*P. ovale*33410 (6.8)*P. vivax*32110117 (11.6)Total (%)9 (6.1)36 (24.5)61 (41.5)12 (8.2)29 (19.7)147

The diagnosis of imported malaria in children {#Sec13}
=============================================

Essential information needed in the laboratory diagnosis of malaria {#Sec14}
-------------------------------------------------------------------

All essential information for diagnosis and patient management can be obtained by microscopy. *Plasmodium* parasites are looked for in a thick blood film, which consists of a superposition of several layers of blood cells. The RBCs are lysed during the staining process, in preference by Giemsa stain. Thin blood films---as regularly used in the hematological laboratory---represent a monolayer of blood, and are used for *Plasmodium* species identification, which is based on morphological characteristics of the RBCs (shape and inclusions) and the *Plasmodium* parasites (Fig. [2](#Fig2){ref-type="fig"}). Fig. 2Giemsa-stained thin blood film of a patient with *P. falciparum* malaria: the patient was sick for 2 weeks before diagnosis. Numerous red blood cells are infected with small trophozoites (ring forms); some red blood cells contain multiple trophozoites. Three banana-shaped gametocytes (visible only after 1 or 2 weeks of clinical infection) are present and the white blood cell (*center*) contains black-brown hemozoin pigment

Apart from not missing the diagnosis of malaria, differentiation of *P. falciparum* from the non-*falciparum* species is important because of the life-threatening potential of this species. Accurate identification of parasite density appears to be difficult in non-endemic settings \[[@CR31]\], but high parasite densities exceeding 2% of RBCs infected should be recognized, as this criterion constitutes an alert sign \[[@CR61]\]. Expert microscopists in reference laboratories will recognize *P. falciparum* stages and hemozoin pigment in white blood cells (WBCs): in the case of *P. falciparum* infection, schizonts and hemozoin-containing WBCs are indicators of a serious infection, whereas the exclusive presence of gametocytes after treatment is a normal finding \[[@CR60]\].

Capillary or venous blood? {#Sec15}
--------------------------

Some authors recommend capillary rather than venous blood as the sample of choice for malaria diagnosis because of a presumed higher parasite density in the former \[[@CR40], [@CR43]\]. However, this assumption has never been confirmed \[[@CR25]\] and for pragmatic reasons, i.e., to assure preparation of (enough) samples of good quality and to allow antigen testing and confirmatory analysis, we advice in our setting to submit a tube of EDTA blood rather than capillary blood specimens.

Details for sampling can be found in reference \[[@CR36]\]. For capillary blood, a non-cotton alcohol pad should be used for cleaning as cotton may leave loose fibers resulting in confusing artifacts \[[@CR43]\]. Thick and thin blood films should be prepared instantly: for the thick film, a blood spot is applied on a slide and stirred in a circular motion with the corner of the slide, taking care not to make the preparation too thick. The slide is allowed to dry without fixative. For venous blood, EDTA is the anticoagulant of choice. Slides should preferable be prepared within 1 h after collection in order to preserve RBC alterations and parasite morphology \[[@CR43]\].

Automated hematology analyzers may trigger the possibility of malaria {#Sec16}
---------------------------------------------------------------------

Some automated hematology analyzers display an alert (flag) in case of malaria suspicion based on the presence of (1) activated monocytes (Coulter Counter), (2) hemozoin-containing white blood cells (Cell-Dyn series), and (3) an additional peak in the reticulocyte fraction (Cell-Dyn series) \[[@CR2], [@CR27], [@CR45], [@CR55]\]. Although diagnostic accuracy of these features is too low to exclusively rely on these flags for malaria diagnosis, the merit of these analyzers is triggering the diagnosis of malaria in patients for whom malaria diagnosis was not requested. As an example, based on flags generated by Cell-Dyn 3200 apparatus used in our laboratory, we retrieved *Plasmodium* parasites in the blood of seven patients over a 3-year period (2008--2010), for whom malaria diagnosis was not considered upon clinical presentation (including an 11-year-old boy with *P. falciparum* infection).

Molecular methods can refine the diagnosis {#Sec17}
------------------------------------------

Molecular techniques such as polymerase chain reaction (PCR) are powerful tools with detection limits below that of expert microscopy. For the time being, they do not generate information about parasite density and their turnaround time is too long to be practicable in clinical diagnosis. In our setting, we developed a real-time four-primer *Plasmodium*-specific PCR as a back-up method for species confirmation and diagnosis of mixed *Plasmodium* infections \[[@CR6]\]. We also converted this method to Giemsa-stained slides and malaria rapid diagnostic tests as the source of DNA, which makes it possible to confirm or refine the diagnosis even when whole blood samples are not available \[[@CR5], [@CR7]\].

Malaria rapid diagnostic tests (MRDTs): simple and accurate {#Sec18}
-----------------------------------------------------------

Malaria rapid diagnostic tests (MRDTs) detect *Plasmodium* antigen by an antibody--antigen reaction on a nitrocellulose strip, which is embedded in a plastic cassette or occasionally in a cardboard format (Fig. [3](#Fig3){ref-type="fig"}). Malaria-positive samples will present cherry-red test lines which are read by the naked eye. Two-band MRDTs are mostly designed to detect *P. falciparum*; they display a control line and a test line which targets either histidine-rich protein-2 (HRP-2) or *P. falciparum*-specific parasite lactate dehydrogenase (Pf-pLDH). Three- and four-band malaria MRDTs display a control line and two or three test lines, one targeting a *P. falciparum*-specific antigen, another line targeting an antigen common to the four species \[either pan-*Plasmodium*-specific lactate parasite dehydrogenase (pan-pLDH) or aldolase\], and, in case of the four-band malaria RDTs, a third line which targets *P. vivax*-specific pLDH (Pv-pLDH). Fig. 3Two- and three-band (*below*) malaria rapid diagnostic tests (MRDTs) with blood transfer devices (pipette and loop). Control and test lines are cherry-red colored. The two-band MRDT (*upper*) displays a control line and a test line which targets *P. falciparum*-specific histidine-rich protein-2 (HRP-2) The three-band MRDT (*below*) displays a control line and two test lines, one targeting HRP-2 and another line targeting pan-parasite lactate dehydrogenase

Figure [4](#Fig4){ref-type="fig"} displays the different components of a MRDT strip and the sequence of reactions on a two-band MRDT strip. Before interpreting test results, the presence of the control line should be confirmed and when absent the test should be repeated. In case of three-band MRDTs, the presence of a single *P. falciparum*-specific test line indicates an infection with *P. falciparum* and the presence of a single pan-*Plasmodium* test line indicates an infection with one of the non-*falciparum* species. When both test lines are present, this indicates an infection with either *P. falciparum* or a mixed infection of *P. falciparum* and one or more of the non-*falciparum* species. Fig. 4Schematic drawing of the malaria rapid diagnostic test. Sequence of events when performing a MRDT: blood and buffer are applied, respectively, to the sample and buffer pad. They are attracted by the capillary action of the absorption pad and start to migrate. First, they pass the conjugate pad, which contains a detection antibody targeting a *Plasmodium* antigen, such as HRP-2, Pf-pLDH, Pv-pLDH, pan-pLDH, or aldolase (for abbreviations see text). This detection antibody is a mouse antibody that is conjugated to a signal, mostly colloidal gold. If present in the sample, the *Plasmodium* antigen is bound to this detection antibody--conjugate. Next, the antigen--antibody--conjugate complex migrates further until it is bound to the capture antibody, which binds to another site of the *Plasmodium* target antigen. As the capture antibody is applied on a narrow section of the strip, the complex with the conjugated signal will be concentrated and by virtue of the colloidal gold will become visible as a cherry-red line. The excess of detection antibody--conjugate that was not bound by the antigen and the capture antibody moves further until it is bound to a goat-raised anti-mouse antibody, thereby generating a control line

Malaria rapid diagnostic tests: different accuracies for the four *Plasmodium* species {#Sec19}
--------------------------------------------------------------------------------------

Nowadays more than 80 MRDT brands are marketed worldwide \[[@CR10]\] and their diagnostic performances may vary. WHO has published two series of diagnostic evaluations \[[@CR58], [@CR63]\] and we have evaluated a set of MRDTs available on the European market \[[@CR36], [@CR37], [@CR51], [@CR52]\]. No studies about diagnostic accuracies of MRDTs in the setting of imported childhood malaria are available, though MRDT performances are assumed not to be different in children compared to adults \[[@CR42]\].

For the diagnosis of *P. falciparum*, MRDTs approach a sensitivity of 100% but they perform less well below parasite densities of 100/μl (corresponding to 0.002% of RBCs). This detection limit generally is above the threshold of expert microscopy (50/μl) but below that of routine microscopy in non-endemic settings, which has been shown to be close to 500/μl \[[@CR40]\]. Of note, however, non-immune travelers can present with symptoms below a parasite density of 100/μl parasite density \[[@CR42]\].

Concerns have risen about rare but persistent reports of false-negative MRDT results at higher parasite densities. One of the explanations is the *hrp* gene deletions that have been found in *P. falciparum* samples in the Peruvian Amazon \[[@CR15]\]. These parasites do not secrete HRP-2, thereby impeding diagnosis by HRP-2-based MRDTs. Further, MRDTs may generate false-negative results in cases of high parasite densities (\>5% of RBCs infected). This is the so-called prozone effect, caused by an excess of antigen blocking the binding sites of both detection and capture antibodies \[[@CR17]\].

For the non-*falciparum* species, reported diagnostic sensitivities vary more and are lower than for *P. falciparum* \[[@CR38]\]. Several MRDT brands have been evaluated at our institute on stored whole blood samples. Reported sensitivities for *P. vivax* ranged from 66.0% to 92.9% with false-negative results especially occurring at low parasite densities \[[@CR36], [@CR37], [@CR51], [@CR52]\]. For *P. ovale* and *P. malariae*, sensitivities were 5.5--80.0% and 21.4--45.2%, respectively \[[@CR36], [@CR37], [@CR51], [@CR52]\]. The lower diagnostic sensitivities for *P. ovale* and *P. malariae* are well known and might be explained by the lower affinity of some monoclonal antibodies to these species \[[@CR22]\]. Though MRDTs can be of help in the diagnosis of malaria, they cannot be used to reliably exclude the non-*falciparum* species, especially *P. ovale* and *P. malariae.*

Malaria rapid diagnostic tests are not fail-proof and have inherent weaknesses {#Sec20}
------------------------------------------------------------------------------

Although useful in the diagnosis of malaria and for the species identification of *P. falciparum*, MRDTs do not provide a reliable indication about parasite density. In addition, the HRP-2 antigen may persist for weeks after treatment and clearing of the parasites \[[@CR38], [@CR40], [@CR42], [@CR66]\], giving rise to apparent false-positive results. Limitations may also arise in performance and interpretation. For instance, problems can occur with the blood transfer device supplied with the MRDT kit (a loop, pipette or a straw---Fig. [3](#Fig3){ref-type="fig"}) which may be too small to manipulate accurately \[[@CR64]\], reason why we advice a transfer pipette. Disregarding faint test lines as negative results is a frequent error among end users \[[@CR46]\], and this is of concern as faint test lines (which are barely visible to the naked eye) may occur in 17.8% of all positive test lines \[[@CR37]\]. Further, reading beyond the recommended reading time must be avoided as this may cause false-positive results \[[@CR56]\]. Finally, inadequacies in MRDT package, labeling, and test instructions have been reported also among CE-labeled kits \[[@CR18], [@CR19]\], which might limit accurate performance and/or test interpretation by end users.

The diagnostic strategy, some comments {#Sec21}
--------------------------------------

There is a tendency among clinical laboratories in non-endemic settings to rely on MRDTs as the single tool for the diagnosis of malaria (especially outside office hours), but for reasons of their limitations, MRDTs should only be used as an adjunct to microscopy. The clinician, who in some cases decides about which laboratory analyses is going to be performed for the diagnosis of malaria, should request both microscopy and MRDTs when filling in the laboratory request form \[[@CR18]\].

Non-immune children may present with symptoms at parasite densities below the detection thresholds of both microscopy and MRDTs. Therefore, laboratory testing after unexpected negative results should be repeated. Repeat testing has been advised every 8--12 h for at least three consecutive samplings \[[@CR13], [@CR14], [@CR67]\]. Of note, there is no need to await a next peak of fever to repeat microscopy or MRDT testing \[[@CR42]\].

Conclusion {#Sec22}
==========

From the above, it is clear that a high index of clinical suspicion and close communication with the laboratory are clues to the timely diagnosis of malaria. VFR children, immigrants, and refugees belong to the highest risk group. Malaria may present months after leaving an endemic area, also in case of *P. falciparum*. Microscopy remains the cornerstone of diagnosis and provides information about parasite density and *Plasmodium* species. It can be complemented by MRDTs which are accurate for the diagnosis and distinction of *P. falciparum* but lack sensitivity for the diagnosis of the non-*falciparum* species. Repeat testing is recommended in case of negative laboratory tests and persistent suspicion of malaria.
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